On Thursday, June 21st, 2018 George Yancopoulos, Regeneron’s CSO & Co-Founder along with other senior leaders will host an invitation-only event in Cambridge, MA, followed by a reception.
Regeneron will provide an overview of its research & development organization, corporate development strategy, therapeutic areas of interest and their novel and fully integrated approaches to partnering.
There will be an opportunity to request meetings with Regeneron prior to the event in their areas of interest. Those interest areas are Ophthalmology, Immuno-oncology, Novel Platform Technologies in Cell Therapy, Gene Therapy, Gene Editing, Antibody Discovery, Human Genetics.
Contact Emily if you are interested in participating, she will put you in touch with MassBio to continue the registration process. Space is limited.